Welcome to our dedicated page for Central Plains Bancshares news (Ticker: CPBI), a resource for investors and traders seeking the latest updates and insights on Central Plains Bancshares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Central Plains Bancshares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Central Plains Bancshares's position in the market.
Central Plains Bancshares (NASDAQ: CPBI) announced a new stock repurchase program authorized by its Board of Directors. The program allows for the repurchase of up to 200,000 shares of common stock, representing approximately 5.0% of current outstanding shares. Repurchases will be conducted through open market or private transactions, block trades, and potential Rule 10b5-1 trading plans. The program's implementation will begin after the Company's regular trading blackout period ends. Management will execute repurchases at their discretion based on market conditions, trading prices, and alternative capital uses. The program can be suspended, terminated, or modified at any time.
FAQ
What is the current stock price of Central Plains Bancshares (CPBI)?
What is the market cap of Central Plains Bancshares (CPBI)?
